Endo starts manufacturing Novavax’s potential COVID-19 vaccine

A doctor lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19.(File/AFP)
Short Url
Updated 25 September 2020

Endo starts manufacturing Novavax’s potential COVID-19 vaccine

  • The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the UK
  • Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product

LONDON: Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc’s experimental COVID-19 vaccine, sending its shares up 10% before the trading bell.
The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the United Kingdom.
Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax’s phase-3 clinical trial in the United States.
Financials and other terms of the non-exclusive agreement were not disclosed.
NVX-CoV2373 is currently also being tested in two ongoing mid-stage trials that began in August.


Russia’s coronavirus death toll passes 25,000

Updated 22 October 2020

Russia’s coronavirus death toll passes 25,000

  • Authorities reported 15,971 new coronavirus infections in the previous 24 hours
MOSCOW: Russia recorded 290 deaths from COVID-19 on Thursday, bringing its official death toll to 25,242.
Authorities reported 15,971 new coronavirus infections in the previous 24 hours, bringing the nationwide total to 1,463,306, the fourth highest in the world.